Skip to main content
Caplight Logo









HVR Cardio International

HVR Cardio International

Private
EspooHealthcare & Life Scienceshttps://hvrcardio.com

Last Round

Series B

Jan 11, 2023

Total Funding Raised

$11.1M

Company Overview

HVR Cardio International is a clinical-stage medical technology company that develops minimally invasive solutions for mitral valve repair based on its proprietary helix technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

mitral valve repairmitral regurgitationtranscatheter devicetranscatheter mitral valve repairstructural heartheart valve repairminimally invasive surgeryTMVRmedical deviceinterventional cardiologyclinical stagecardiovascular deviceTAVR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HVR Cardio International Comparables

Compare HVR Cardio International with similar companies based on industry and business-model similarity.

HVR Cardio International comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Valcare Medical
89%
Cardiac Dimensions
86%
NeoChord
85%

HVR Cardio International Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 11, 2023
VC RoundNov 30, 2015

Key People

Founding team and executive leadership

Tim Girton

Chief Technology Officer

Executive Team

HVR Cardio International Investors

Notable investors and investment history

HVR Cardio International investors
InvestorRounds
TesiSeries B
InnovestorSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 64% MoM, reaching 2.6K.

  • May 11, 2026

    Monthly visitors increased 64% MoM, reaching 2.6K.

HVR Cardio International Filings

Explore SEC and related filing metadata, where available.

HVR Cardio International filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HVR Cardio International's valuation, stock price, and market status.

Is HVR Cardio International a public or private company?

HVR Cardio International is a private company.

What is the current stock price of HVR Cardio International?

HVR Cardio International is a private company, so its shares have no public market price. Caplight tracks HVR Cardio International's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is HVR Cardio International worth (valuation)?

Valuation information for HVR Cardio International is not publicly available.

Can I buy HVR Cardio International stock?

HVR Cardio International shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was HVR Cardio International's last funding round?

HVR Cardio International's most recent funding round was Series B on January 11, 2023.

Who are the main investors in HVR Cardio International?

Key investors in HVR Cardio International include Tesi, Innovestor.

Will HVR Cardio International IPO soon?

No public IPO plans have been announced for HVR Cardio International.

How can I track HVR Cardio International secondary market activity?

Caplight tracks bids, offers, and trades in HVR Cardio International's shares on secondary markets.

Firmographic Details

HeadquartersEspoo
Employee Range8
Year Founded2002
Last FundingJan 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?